¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑ¿ì¿ïÁ¶¿ïº´ÇÐȸ Ãß°èÇмú´ëȸ ¹× ¿¬¼ö±³À° : 2021-09-03

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑ¿ì¿ïÁ¶¿ïº´ÇÐȸ Ãß°èÇмú´ëȸ ¹× ¿¬¼ö±³À° : 2021-09-03
±³À°ÀÏÀÚ : 2021-09-03
±³À°Àå¼Ò : ¼­¿ï ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ ¹× ´ëȸÀǽǠ 
±³À°ÁÖÁ¦ : ´ëÇÑ¿ì¿ïÁ¶¿ïº´ÇÐȸ Ãß°èÇмú´ëȸ ¹× ¿¬¼ö±³À°
ÁÖÃÖ±â°ü : ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑ¿ì¿ï.Á¶¿ïº´ÇÐȸ (ÀÌ»çÀåÁ¦)  
´ã´çÀÚ : ´ëÇÑ¿ì¿ïÁ¶¿ïº´ÇÐȸ »ç¹«±¹
¿¬¶ôó : 02-3779-1250  
À̸ÞÀÏ : webmaster@thekasad.or.kr      
±³À°Á¾·ù : Á¤½Å°Ç°­ÀÇÇаú      
Âü¼®¿¹»óÀοø : 90¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 13 ½Ã°£ 20ºÐ  
¼¼ºÎ¼ö°­·á : 80,000¿ø      
ºñ°í »çÀüµî·Ï: Á¤È¸¿ø 5¸¸¿ø, ÁØȸ¿ø 3¸¸¿ø, ºñȸ¿ø 6¸¸¿ø, Æò»ýȸ¿ø ¸éÁ¦ ´çÀϵî·Ï: Á¤È¸¿ø 6¸¸¿ø, ÁØȸ¿ø 4¸¸¿ø, ºñȸ¿ø 8¸¸¿ø, Æò»ýȸ¿ø 1¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09-03 ÄÁº¥¼ÇȦ 09:30~09:50 Mood and personal traits as risk factors for physical illness  È«Á¤¿Ï(Àͻ꺴¿ø) 
±³À°½Ã°£ 09-03 ÄÁº¥¼ÇȦ 09:50~10:10 Inflammation, physical illness, and depression  ½Å»óÈ£(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 09-03 ÄÁº¥¼ÇȦ 10:10~10:40 Metabolic syndrome and bipolar disorder  °­¿ø¼·(°æÈñÀÇ´ë) 
±³À°½Ã°£ 09-03 ÄÁº¥¼ÇȦ 10:55~11:15 Antidepressants: Minimalist vs. maximalist view  ¹Ú¼º¿ë(°è¿äº´¿ø) 
±³À°½Ã°£ 09-03 ÄÁº¥¼ÇȦ 11:15~11:35 Antipsychotics: Evidence based treatment vs. potential treatment  ¹Ú¿µ¹Î(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 09-03 ÄÁº¥¼ÇȦ 11:35~12:05 Augmentation therapy: Focus on dopamine agonist & stimulant  Á¤¸íÈÆ(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 09-03 ÄÁº¥¼ÇȦ 12:05~12:35 Anxiety & depression in the COVID pandemia  ¿ì¿µ¼·(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 09-03 ÄÁº¥¼ÇȦ 12:35~13:05 Benefits of Agomelatine treatment strategies  Á¤Á¾Çö(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 09-03 ÄÁº¥¼ÇȦ 13:20~13:35 ¡®Irritability¡¯ as a symptom of depression for children and adolescents?  À̹®¼ö(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 09-03 ÄÁº¥¼ÇȦ 13:35~13:50 What can tell the differences between bipolar disorder and ADHD?  ½É¼¼ÈÆ(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 09-03 ÄÁº¥¼ÇȦ 13:50~14:05 Are there cognitive dysfunctions in bipolar disorder?  ¿Õ¼º¹Î(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 09-03 ÄÁº¥¼ÇȦ 14:05~14:30 What is the vascular depression hypothesis?  ÀÌ°­¼ö(Â÷ÀÇ°úÇдë) 
±³À°½Ã°£ 09-03 ÄÁº¥¼ÇȦ 14:30~14:50 Major depressive disorder  ¿ì¿µ¼·(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 09-03 ÄÁº¥¼ÇȦ 14:50~15:10 Bipolar disorder: Manic episode and mixed features  ¹®Àº¼ö(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 09-03 ÄÁº¥¼ÇȦ 15:10~15:40 Bipolar disorder: Depressive episode  ÀÓÀº¼º(½Å¼¼°èÈ¿º´¿ø) 
±³À°½Ã°£ 09-03 ÄÁº¥¼ÇȦ 15:50~16:10 Navigating the world of ADHD medications  ¾çÂù¸ð(¿ø±¤ÀÇ´ë) 
±³À°½Ã°£ 09-03 ÄÁº¥¼ÇȦ 16:10~16:30 Diagnosing and treating major depressive episodes with mixed features  ½ÉÀÎÈñ(µ¿³²±Ç¿øÀÚ·ÂÀÇÇпø) 
±³À°½Ã°£ 09-03 ÄÁº¥¼ÇȦ 16:30~17:00 Long-acting injectable antipsychotics in bipolar disorder  ±è°æ¹Î(±¹¸³³ªÁÖº´¿ø) 
±³À°½Ã°£ 09-03 ´ëȸÀǽǠ09:30~09:50 Suicide rate and risk factors in pandemic  °­ÇÑ°íÀººñ(±¹¸³³ªÁÖº´¿ø) 
±³À°½Ã°£ 09-03 ´ëȸÀǽǠ09:50~10:10 Immunity, suicide and COVID-19: A linking pathway  Àå½ÂÈ£(¿ø±¤ÀÇ´ë) 
±³À°½Ã°£ 09-03 ´ëȸÀǽǠ10:10~10:40 Suicide prevention during COVID-19  ¿ÀÈ«¼®(°Ç¾çÀÇ´ë) 
±³À°½Ã°£ 09-03 ´ëȸÀǽǠ10:55~11:55 Mindfulness-based interventions for depression  ±¸º»ÈÆ(¿µ³²ÀÇ´ë) 
±³À°½Ã°£ 09-03 ´ëȸÀǽǠ12:05~12:35 Importance of multifactorial condition management  ¼ºÇü¸ð(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 09-03 ´ëȸÀǽǠ12:35~13:05 Successful management of patient adherence  ³²¹ü¿ì(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 09-03 ´ëȸÀǽǠ13:20~13:40 Glutamatergic system  ¼Û¹Î±Ô(¼º¸ð°ø°¨Á¤½Å°Ç°­ÀÇÇаúÀÇ¿ø) 
±³À°½Ã°£ 09-03 ´ëȸÀǽǠ13:40~14:00 GABAergic system  ±èÅÂÈñ(¿¬¼¼¿øÁÖÀÇ´ë) 
±³À°½Ã°£ 09-03 ´ëȸÀǽǠ14:00~14:30 Inflammatory system  ÀÌÁ¤±¸(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 09-03 ´ëȸÀǽǠ14:30~15:00 Overview and CBT approaches  ±è¿ø(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 09-03 ´ëȸÀǽǠ15:00~15:30 Family interventions  Á¤¿µÀº(Á¦ÁÖÀÇ´ë) 
±³À°½Ã°£ 09-03 ´ëȸÀǽǠ15:50~16:10 PTSD and depression after trauma exposure  À̺´Ã¶(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 09-03 ´ëȸÀǽǠ16:10~16:30 Biological underpinnings of trauma and depression  ±èÁö¼±(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 09-03 ´ëȸÀǽǠ16:30~17:00 Treating depression of victims  ±è¿øÇü(ÀÎÇÏÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑ¿ì¿ïÁ¶¿ïº´ÇÐȸ Ãß°èÇмú´ëȸ ¹× ¿¬¼ö±³À° : 2021-09-03""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѺñ¸¸ÇÐȸ ICOMES 2021 (2ÀÏÂ÷) : 2021-09-03
´ÙÀ½±Û ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ (¿Â¶óÀÎ) International Colorectal Research Summit 2021-Precongress (1ÀÏÂ÷) : 2021-09-03
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20664 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø (¿Â¶óÀÎ)¼Ò¾Æû¼Ò³â°ú Çù·ÂÀÇ»ç Áý´ãȸ : 2024-05-28 0 33 2024-05-10
20663 ºÎ»ê ´ëÇѳ»°úÀÇ»çȸ Á¦1ȸ ÃÊÀ½ÆÄ ½ÇÀü ¾ÆÄ«µ¥¹Ì : 2024-05-27 0 41 2024-05-10
20662 ¼­¿ï ´ëÇѿ°èÁٱ⼼Æ÷Àç»ýÀÇÇÐȸ - Á¦20ȸ Ãá°èÇмú´ëȸ (ÇÏÀ̺긮µå) : 2024-05-26 0 22 2024-05-10
20661 ºÎ»ê ´ëÇÑ°áÇÙ ¹× È£Èí±âÇÐȸ ºÎ¿ï°æÁöȸ 5¿ù ¿¬¼ö°­Á : 2024-05-26 0 32 2024-05-10
20660 ¼­¿ï ´ëÇѽŰæ±Ù°ñ°áÃÊÀ½ÆÄÇÐȸ Á¦1ȸ ÇÚÁî¿Â ¿öÅ©¼ó : 2024-05-25 0 28 2024-05-10
20659 ´ëÀü ´ëÇÑÀ̺ñÀÎÈÄ°úÀÇ»çȸ 2024 Áöȸ½ÉÆ÷Áö¾ö-´ëÀüÃæ³² : 2024-05-25 0 18 2024-05-10
20658 ºÎ»ê ´ëÇÑÀÎÅͺ¥¼Ç¿µ»óÀÇÇÐȸ Á¦32Â÷ Á¤±âÇмú´ëȸ(2ÀÏÂ÷) : 2024-05-25 0 18 2024-05-10
20657 ´ë±¸ Ä¥°î°æºÏ´ëÇб³º´¿ø The 1st International Symposium on Precision Oncology in Breast Cancer : 2024-05-25 0 18 2024-05-10
20656 ¼­¿ï (¿Â¶óÀÎ)2024³â ´ëÇÑ°ñ´ë»çÇÐȸ Á¦1Â÷ FLS ÄÚµð³×ÀÌÅÍ ¿öÅ©¼ó : 2024-05-24 0 22 2024-05-10
20655 ¼­¿ï Á¦ 66ȸ Çѱ¹Ç×°ø¿ìÁÖÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-24 0 11 2024-05-10
20654 ´ëÀü °ø°ø±â°ü ÀçÁ÷ÀÇ»ç Ãá°è Çмú´ëȸ (2ÀÏÂ÷) : 2024-05-24 0 19 2024-05-10
20653 ºÎ»ê ´ëÇÑÀÎÅͺ¥¼Ç¿µ»óÀÇÇÐȸ Á¦32Â÷ Á¤±âÇмú´ëȸ(1ÀÏÂ÷) : 2024-05-24 0 20 2024-05-10
20652 ¼­¿ï Çѱ¹Ç÷ÀüÁöÇ÷ÇÐȸ Á¦ 44 Â÷ KSTH Ãá°èÇмú´ëȸ : 2024-05-24 0 24 2024-05-10
20651 ¼­¿ï (¿Â¶óÀÎ)À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»çÁý´ãȸ-°³¿ø°¡¿¡¼­ ÀÇ·ÚµÈ ÀÌ°ú Áúȯ : 2024-05-23 0 22 2024-05-10
20650 °æ±â Çϳ²½ÃÀÇ»çȸ¿¬¼ö°­ÁÂ(¸¸¼º±âħ, ºÒ¸éÁõ) : 2024-05-23 0 11 2024-05-10
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷